Journal of Current Oncology

: 2018  |  Volume : 1  |  Issue : 1  |  Page : 35--39

Radiobiology of re-irradiations

B Nanditha Sesikeran1, Sayan Paul1, Kanhu Charan Patro2, Manoj K Gupta3 
1 Department of Radiation Oncology, Apollo Cancer Institute, Hyderabad, Telangana, India
2 Department of Radiation Oncology, Mahatma Gandhi Cancer Hospital, Vishakhapatnam, Andhra Pradesh, India
3 Department of Radiotherapy, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India

Correspondence Address:
Dr. B Nanditha Sesikeran
Apollo Cancer Institute, Apollo Health City Hospital, Jubilee Hills, Hyderabad, Telangana

The treatment options for recurrent tumors are limited. Re irradiation is being increasingly considered as an option, in view of the advances in treatment techniques, particularly the ability to document doses, overlay plans, intensity modulation, and image guidance. preclinical and clinical studies has been to estimate the total cumulative doses (EQD2) also termed as normalized total dose (NTD) that can be delivered to various tissues. In this review article reirradiation radiobiology of different tissues and dose fractionation have been discussed.

How to cite this article:
Sesikeran B N, Paul S, Patro KC, Gupta MK. Radiobiology of re-irradiations.J Curr Oncol 2018;1:35-39

How to cite this URL:
Sesikeran B N, Paul S, Patro KC, Gupta MK. Radiobiology of re-irradiations. J Curr Oncol [serial online] 2018 [cited 2023 Jun 7 ];1:35-39
Available from: http://www.;year=2018;volume=1;issue=1;spage=35;epage=39;aulast=Sesikeran;type=0